Skip to main content

Table 4 Associations between the original/hybrid 4-stratum model and clinical outcome

From: The original and two new derivative versions of the COMPERA 2.0 risk assessment model: useful tools for guiding balloon pulmonary angioplasty

Outcome

No. of patients

No. of events

Crude HRd (95% CI)

P for trend

Primary endpoint-clinical worsening

 Original 4-stratum model before the 1st BPA

  Low

37

1

1 (reference)

< 0.001

  Intermediate-low

52

3

2.411 (0.251–23.197)

  Intermediate-high

74

18

10.579 (1.411–79.288)

  High

12

4

12.524 (1.397–112.234)

 Original 4-stratum model after the 1st BPA

  Low

77

4

1 (reference)

< 0.001

  Intermediate-low

70

10

3.376 (1.057–10.777)

  Intermediate-high

25

12

14.716 (4.709–45.989)

  High

3

0

NAa

 Hybrid 4-stratum model before the 1st BPA

  Low

37

1

1 (reference)

< 0.001

  Intermediate-low

52

3

2.418 (0.251–23.264)

  Intermediate-high

38

6

5.162 (0.612–42.911)

  High

48

16

18.661 (2.471–140.916)

 Hybrid 4-stratum model after the 1st BPA

  Low

77

4

1 (reference)

< 0.001

  Intermediate-low

70

10

3.381 (1.059–10.795)

  Intermediate-high

20

9

15.346 (4.684–50.283)

  High

8

3

9.113 (2.021–41.100)

Secondary endpoint-achieving low riskb

 Original 4-stratum model before the 1st BPA

  Intermediate-low

52

43

1 (reference)

< 0.001

  Intermediate-high

74

37

0.209 (0.089–0.490)

  High

12

4

0.105 (0.026–0.424)

 Hybrid 4-stratum model before the 1st BPA

  Intermediate-low

52

43

1 (reference)

< 0.001

  Intermediate-high

48

31

0.382 (0.150–0.968)

  High

38

10

0.075 (0.027–0.207)

Secondary endpoint-achieving mPAP < 30 mmHgc

 Original 4-stratum model before the 1st BPA

    

  Low

23

12

1 (reference)

< 0.001

  Intermediate-low

33

10

0.399 (0.132–1.203)

  Intermediate-high

56

9

0.176 (0.059–0.520)

  High

7

0

NAa

 Hybrid 4-stratum model before the 1st BPA

    

  Low

23

12

1 (reference)

< 0.001

  Intermediate-low

33

10

0.399 (0.132–1.203)

  Intermediate-high

42

8

0.216 (0.070–0.663)

  High

21

1

0.046 (0.005–0.401)

  1. BPA balloon pulmonary angioplasty, mPAP mean pulmonary arterial pressure
  2. aNo event happened and HR/OR could not be calculated
  3. bOnly patients with intermediate-low risk or higher grade at baseline were included in the analysis
  4. cOnly patients with mPAP ≥ 30 mmHg at baseline were included in the analysis
  5. dResults of multivariable regression were provided in Additional file 2